TR201900240T4 - Gece idrara çıkışları azaltmak için desmopresin. - Google Patents

Gece idrara çıkışları azaltmak için desmopresin. Download PDF

Info

Publication number
TR201900240T4
TR201900240T4 TR2019/00240T TR201900240T TR201900240T4 TR 201900240 T4 TR201900240 T4 TR 201900240T4 TR 2019/00240 T TR2019/00240 T TR 2019/00240T TR 201900240 T TR201900240 T TR 201900240T TR 201900240 T4 TR201900240 T4 TR 201900240T4
Authority
TR
Turkey
Prior art keywords
desmopressin
urination
nighttime urination
reduce nighttime
administration
Prior art date
Application number
TR2019/00240T
Other languages
English (en)
Turkish (tr)
Inventor
Peter Norgaard Jens
Mirner Klein Bjarke
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of TR201900240T4 publication Critical patent/TR201900240T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR2019/00240T 2010-03-25 2011-03-22 Gece idrara çıkışları azaltmak için desmopresin. TR201900240T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/732,161 US20100286045A1 (en) 2008-05-21 2010-03-25 Methods comprising desmopressin

Publications (1)

Publication Number Publication Date
TR201900240T4 true TR201900240T4 (tr) 2019-02-21

Family

ID=44365354

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00240T TR201900240T4 (tr) 2010-03-25 2011-03-22 Gece idrara çıkışları azaltmak için desmopresin.

Country Status (16)

Country Link
US (3) US20100286045A1 (enExample)
EP (3) EP2550007B1 (enExample)
JP (3) JP6253977B2 (enExample)
CN (4) CN102821776A (enExample)
CA (1) CA2793502A1 (enExample)
DK (2) DK3006036T3 (enExample)
ES (2) ES2559446T3 (enExample)
HR (1) HRP20190104T1 (enExample)
HU (1) HUE027417T2 (enExample)
LT (1) LT3006036T (enExample)
PL (2) PL3006036T3 (enExample)
PT (2) PT2550007E (enExample)
RS (1) RS58224B1 (enExample)
SI (1) SI3006036T1 (enExample)
TR (1) TR201900240T4 (enExample)
WO (1) WO2012001469A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US20160098530A1 (en) * 2014-10-07 2016-04-07 David A. DILL Devices and methods for managing risk profiles
JP7482033B2 (ja) 2018-10-17 2024-05-13 日本ケミファ株式会社 夜間多尿の治療又は予防剤
WO2022103638A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Cannabinoids in the treatment of autism spectrum disorder
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US12214010B2 (en) 2023-04-04 2025-02-04 Tulex Pharmaceuticals Inc. Desmopressin oral compositions

Family Cites Families (154)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
EP0084705B1 (en) 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
TW279133B (enExample) 1990-12-13 1996-06-21 Elan Med Tech
SE9101022D0 (sv) 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
DE69231536T2 (de) 1991-08-26 2001-06-13 Abbott Laboratories, Abbott Park Verbindungen und methoden zur sublingualen oder buccalen verabreichung von therapeutischen agentien
DE69227467T2 (de) 1991-12-24 1999-04-22 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo Intrabukkal desintegrierende zubereitung und ihre herstellung
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
NZ268442A (en) 1993-06-29 1996-09-25 Ferring Bv Aqueous composition of desmopressin for nasal spray administration
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
PT710243E (pt) 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
US5707648A (en) 1993-11-17 1998-01-13 Lds Technologies, Inc. Transparent liquid for encapsulated drug delivery
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
DE19518932C2 (de) 1994-05-23 1999-03-18 Samsung Electro Mech Vorrichtung zur Perforation der Haut für die Vorbereitung einer transdermalen Medikation
SE518619C2 (sv) 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
ZA975326B (en) 1996-06-18 1998-01-14 Alza Corp Device and method for enhancing transdermal flux of agents being delivered or sampled.
US5763398A (en) 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6511974B1 (en) 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US5932745A (en) 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US6090803A (en) 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6344451B1 (en) 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
ATE283708T1 (de) 1999-02-15 2004-12-15 Sumitomo Pharma Im mundraum schnellzerfallende tabletten
HK1041228A1 (zh) 1999-02-18 2002-07-05 Biovalve Technologies, Inc. 电活动孔
AR014640A1 (es) 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US9189777B1 (en) 1999-09-20 2015-11-17 Security First Corporation Electronic commerce with cryptographic authentication
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
CA2396569C (en) 2000-01-07 2010-03-23 Biovalve Technologies, Inc. Injection device
US20070032410A1 (en) 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
TWI287984B (en) 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
ES2322023T3 (es) 2000-10-26 2009-06-16 Alza Corporation Dispositivos de administracion transdermica de farmacos que presentan unas microprotuberancias recubiertas.
KR20030071780A (ko) 2000-11-30 2003-09-06 바이오밸브 테크놀로지스, 인코포레이티드 주입기
ES2574917T3 (es) 2000-11-30 2016-06-23 Valeritas, Inc. Sistemas y procedimientos de suministro y medición de fluido
EP1345646A2 (en) 2000-12-14 2003-09-24 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
ATE364380T1 (de) 2001-03-16 2007-07-15 Alza Corp Transdermales pflaster zur verabreichung von fentanyl
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
DE60218646T2 (de) 2001-04-12 2007-11-22 Wyeth N-biphenylcarbonyl- und n-phenylpyridylcarbonyl substituierte bi- und tricyclische azepine und diazepine als vasopressin-agonisten
DE60222879T2 (de) 2001-04-12 2008-07-24 Wyeth Cyclohexylphenyl vasopressin agonisten
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
DE60229404D1 (de) 2001-09-13 2008-11-27 Kissei Pharmaceutical Kristalle eines hydroxynorephedrinderivats
US6723077B2 (en) 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
JP4075064B2 (ja) 2001-11-16 2008-04-16 アステラス製薬株式会社 ４，４−ジフルオロ−１，２，３，４−テトラヒドロ−５ｈ−１−ベンゾアゼピン誘導体又はその塩
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
PT1501534E (pt) * 2002-05-07 2006-09-29 Ferring Bv Formulacoes farmaceuticas
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
GB2421689B (en) 2002-08-05 2007-03-07 Caretek Medical Ltd Drug delivery system
US20040115167A1 (en) 2002-09-30 2004-06-17 Michel Cormier Drug delivery device and method having coated microprojections incorporating vasoconstrictors
CA2501389C (en) 2002-10-09 2013-01-08 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
AU2004234258B2 (en) 2003-04-28 2009-04-09 Tacurion 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative or salt thereof
US20060193825A1 (en) 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
PL1638468T3 (pl) 2003-06-30 2008-01-31 Alza Corp Sposób powlekania mikrowystępów do przekłuwania skóry
DE60301351T2 (de) 2003-07-25 2006-01-19 Ferring B.V. Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US6930932B2 (en) 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
AU2004285481A1 (en) 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
BRPI0415466A (pt) 2003-10-24 2006-12-19 Alza Corp método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos
EP1680154B1 (en) 2003-10-31 2012-01-04 ALZA Corporation Self-actuating applicator for microprojection array
AU2003287591C1 (en) * 2003-11-10 2009-12-10 Serenity Pharmaceuticals Llc Pharmaceutical compositions including low dosages of desmopressin
ES2260563T3 (es) 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
FR2862230B1 (fr) 2003-11-17 2005-12-16 Rossignol Sa Fixation de surf
SI1550439T1 (sl) 2003-12-29 2006-08-31 Ferring Bv Postopek za pripravo trdne dozirne oblike dezmopresina
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
EP1706176A4 (en) 2004-01-09 2008-06-25 Alza Corp METHOD AND SYSTEM FOR FREQUENCY-ASSISTED TRANSDERMAL-BASED TRANSDERMAL AGENT DELIVERY
GB0406048D0 (en) * 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
DK1797109T3 (en) 2004-09-09 2016-04-11 Yeda Res & Dev MIXTURES OF POLYPEPTIDES, compositions containing them and methods for their preparation, and uses thereof
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US20080009800A1 (en) 2004-12-02 2008-01-10 Nickel Janice H Transdermal drug delivery device
US7180274B2 (en) 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
CN101175740A (zh) 2005-04-22 2008-05-07 惠氏公司 二氢苯并呋喃衍生物和其用途
CN101203216A (zh) 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
RU2007139541A (ru) 2005-04-22 2009-05-27 Вайет (Us) Производные хромана и хромена и их применение
CN101203218A (zh) 2005-04-22 2008-06-18 惠氏公司 苯并呋喃基链烷胺衍生物和其作为5－ht2c激动剂的用途
BRPI0610046A2 (pt) 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
US20060258712A1 (en) 2005-04-24 2006-11-16 Wyeth Methods for modulating bladder function
WO2006138719A2 (en) 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
EP1904158B1 (en) 2005-06-24 2013-07-24 3M Innovative Properties Company Collapsible patch with microneedle array
WO2007021970A2 (en) 2005-08-15 2007-02-22 Praecis Pharmaceuticals, Inc. Stable pharmaceutical formulations and methods of use thereof
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
WO2007098945A2 (en) 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
US8101114B2 (en) 2006-05-01 2012-01-24 Georgia Tech Research Corporation Particle based molding
CN101801452B (zh) 2007-08-06 2014-10-22 阿勒根公司 用于去氨加压素药物给送的设备
LT3225249T (lt) * 2008-05-21 2019-01-10 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas pirminio miego periodo, nepertraukiamo nikturija, pailginimui
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
JP5151774B2 (ja) 2008-07-29 2013-02-27 株式会社リコー クリーニング装置、プロセスユニット及び画像形成装置
US20150306170A1 (en) 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release

Also Published As

Publication number Publication date
CA2793502A1 (en) 2012-01-05
ES2708973T3 (es) 2019-04-12
HRP20190104T1 (hr) 2019-03-08
JP6253977B2 (ja) 2017-12-27
HUE027417T2 (en) 2016-10-28
PT2550007E (pt) 2016-02-15
DK2550007T3 (en) 2016-01-18
PL3006036T3 (pl) 2019-04-30
CN107252474A (zh) 2017-10-17
EP3006036A1 (en) 2016-04-13
EP2550007B1 (en) 2015-10-21
JP6297616B2 (ja) 2018-03-20
JP6545778B2 (ja) 2019-07-17
JP2016153420A (ja) 2016-08-25
EP2550007A1 (en) 2013-01-30
EP3449908A1 (en) 2019-03-06
US20190134146A1 (en) 2019-05-09
US11020448B2 (en) 2021-06-01
JP2018076344A (ja) 2018-05-17
CN110898207A (zh) 2020-03-24
JP2013523628A (ja) 2013-06-17
SI3006036T1 (sl) 2019-02-28
HK1216298A1 (en) 2016-11-04
CN106924716A (zh) 2017-07-07
PL2550007T3 (pl) 2016-04-29
US10137167B2 (en) 2018-11-27
ES2559446T3 (es) 2016-02-12
US20100286045A1 (en) 2010-11-11
LT3006036T (lt) 2019-02-25
DK3006036T3 (en) 2019-02-25
CN102821776A (zh) 2012-12-12
HK1179156A1 (zh) 2013-09-27
RS58224B1 (sr) 2019-03-29
EP3006036B1 (en) 2018-10-31
US20140113863A1 (en) 2014-04-24
PT3006036T (pt) 2019-01-17
WO2012001469A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
FR25C1032I1 (fr) Conjugues anticorps humain-medicament contre le facteur tissulaire
AU335964S (en) Surgical stent
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
TR201900240T4 (tr) Gece idrara çıkışları azaltmak için desmopresin.
AU335963S (en) Surgical cuff
NZ602953A (en) Phytocannabinoids in the treatment of cancer
ZA201206425B (en) Use of erbb3 inhibitors in the treatment of treatment of triple negative and basal-like breast cancers
TR201203732T1 (tr) Opioid antagonistlerin topikal bileşimleri ve deri hastalıklarının bu bileşimler ile tedavisi için yöntemler.
EP2606120A4 (en) HUMAN RELIEF CELLS AND ITS APPLICATIONS
EP2911684A4 (en) IL-15R ALPHA FORMS, IL-15R ALPHA FORMS EXPRESSIVE CELLS, AND THERAPEUTIC USE OF IL-15R ALPHA AND IL-15 / IL-15R ALPHA COMPLEXES
IL215227A0 (en) Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
SMT201600182B (it) Ligandi sigma per l'uso nella prevenzione e/o nel trattamento del dolore post-operatorio
AU329027S (en) Diagnostic device
EP2516429A4 (en) PAXILLIN STIMULATING COMPOSITIONS AND THEIR COSMETIC USE
AU334516S (en) Bowl
MY160556A (en) Neuregulin antagonists and use thereof in treating cancer
IN2014DN08385A (enExample)
AU346744S (en) Organ or tissue cradle
BR112013014915A2 (pt) composição curativa e métodos de tratamento
TR201200950T1 (tr) İlerlemiş meme kanseri tedavisi için 500 mg'lik bir dozajda fulvestrant.
UA108975C2 (uk) Застосування співполімеру натрійкарбоксиметилцелюлози і госиполу в комплексній терапії пацієнтів з аутистичними розладами і когнітивними порушеннями
MX2014012535A (es) Terapia de combinacion de anticuerpos anti-mif y quimioterapeuticos.
EP2619571A4 (en) HUMAN B1 CELLS AND APPLICATIONS THEREOF
UA44395U (ru) Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.